TIGENIX news, videos and press releases
For more news please use our advanced search feature.
TIGENIX - More news...
TIGENIX - More news...
- Takeda Completes its Acquisition of TiGenix Following Expiration of the Squeeze-out Period
- TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
- Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
- TiGenix: Transparency Information
- TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- Transparency notification pursuant to Article 14 of the Law of May 2, 2007
- TiGenix announces a change in its Board of Directors and its Management Team
- Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: CONVENING NOTICE TO THE ANNUAL SHAREHOLDERS' MEETING TO BE HELD ON 7 JUNE 2018
- TiGenix: Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
- TiGenix reports 2017 full year results
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe
- TiGenix: Transparency Information
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix:Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency Information
- TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601
- Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
- TiGenix: Transparency Information
- Takeda announces its intention to acquire TiGenix
